• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

黑热病后皮肤利什曼病、艾滋病和肺结核。

Post-kala-azar dermal leishmaniasis (PKDL), HIV and pulmonary tuberculosis.

作者信息

Das V N R, Pandey K, Verma N, Bimal S, Lal C S, Singh D, Das P

机构信息

Rajendra Memorial Research Institute of Medical Sciences (Indian Council of Medical Research), Agamkuan, Patna 800007, Bihar, India.

出版信息

Natl Med J India. 2010 Mar-Apr;23(2):88-9.

PMID:20925205
Abstract

Post-kala-azar dermal leishmaniasis is usually a sequel to visceral leishmaniasis. A 25-year-old woman presented with hypopigmented maculopapular lesions all over the body for the past 4 years without any previous history of visceral leishmaniasis. She was on treatment for leprosy and pulmonary tuberculosis for the past 2 months, but did not show any improvement. Investigations confirmed that she had post-kala-azar dermal leishmaniasis associated with pulmonary tuberculosis and HIV-1 infection. She was started on treatment for the triad of diseases, and showed improvement.

摘要

黑热病后皮肤利什曼病通常是内脏利什曼病的后遗症。一名25岁女性在过去4年全身出现色素减退性斑丘疹病变,既往无内脏利什曼病病史。她在过去2个月一直在接受麻风病和肺结核治疗,但未见任何改善。检查证实她患有与肺结核和HIV-1感染相关的黑热病后皮肤利什曼病。她开始接受针对这三种疾病的治疗,并有所改善。

相似文献

1
Post-kala-azar dermal leishmaniasis (PKDL), HIV and pulmonary tuberculosis.黑热病后皮肤利什曼病、艾滋病和肺结核。
Natl Med J India. 2010 Mar-Apr;23(2):88-9.
2
Post-kala-azar dermal leishmaniasis as an immune reconstitution inflammatory syndrome in a patient with acquired immune deficiency syndrome.黑热病后皮肤利什曼病作为获得性免疫缺陷综合征患者的免疫重建炎症综合征。
Br J Dermatol. 2007 Nov;157(5):1032-6. doi: 10.1111/j.1365-2133.2007.08157.x. Epub 2007 Sep 13.
3
Post-kala-azar dermal leishmaniasis (PKDL): the first case report from Nepal.黑热病后皮肤利什曼病(PKDL):尼泊尔的首例病例报告。
Southeast Asian J Trop Med Public Health. 2003 Mar;34(1):22-3.
4
Increasing incidence of post-kala-azar dermal leishmaniasis in a population-based study in Bangladesh.在孟加拉国的一项基于人群的研究中,黑热病后皮肤利什曼病的发病率不断增加。
Clin Infect Dis. 2010 Jan 1;50(1):73-6. doi: 10.1086/648727.
5
Short report: Development of post-kala-azar dermal leishmaniasis (PKDL) in miltefosine-treated visceral leishmaniasis.简短报告:米替福新治疗内脏利什曼病后出现的黑热病后皮肤利什曼病(PKDL)
Am J Trop Med Hyg. 2009 Mar;80(3):336-8.
6
Post kala-azar dermal leishmaniasis (PKDL): a first case report from Nepal.黑热病后皮肤利什曼病(PKDL):尼泊尔首例病例报告。
Indian J Pathol Microbiol. 2003 Apr;46(2):214-5.
7
Post kala azar dermal leishmaniasis in Sudan.苏丹的黑热病后皮肤利什曼病
East Mediterr Health J. 2001 Nov;7(6):1061-4.
8
Post kala-azar dermal leishmaniasis: the Kenyan experience.黑热病后皮肤利什曼病:肯尼亚的经验
East Afr Med J. 1991 Oct;68(10):801-6.
9
Successful treatment of post-kala-azar dermal leishmaniasis (PKDL) in a HIV infected patient with multiple relapsing leishmaniasis from Western Europe.成功治疗一名来自西欧的、患有多重复发性利什曼病的HIV感染患者的黑热病后皮肤利什曼病(PKDL)。
J Infect. 2006 Jul;53(1):e25-7. doi: 10.1016/j.jinf.2005.09.015. Epub 2005 Nov 7.
10
Post-kala-azar dermal leishmaniasis in visceral leishmaniasis-endemic communities in Bihar, India.印度比哈尔邦内脏利什曼病流行地区的黑热病后皮肤利什曼病。
Trop Med Int Health. 2012 Nov;17(11):1345-8. doi: 10.1111/j.1365-3156.2012.03067.x. Epub 2012 Aug 12.

引用本文的文献

1
Combination Therapy for Post-Kala-Azar Dermal Leishmaniasis: A Literature Review of Current Evidence.黑热病后皮肤利什曼病的联合治疗:当前证据的文献综述
Indian J Dermatol. 2024 Sep-Oct;69(5):396-405. doi: 10.4103/ijd.ijd_612_22. Epub 2024 Oct 29.
2
Post-kala-azar dermal leishmaniasis (PKDL) drug efficacy study landscape: A systematic scoping review of clinical trials and observational studies to assess the feasibility of establishing an individual participant-level data (IPD) platform.无鞭毛体利什曼病(PKDL)药物疗效研究现状:一项系统评价临床试验和观察性研究的范围界定,以评估建立个体参与者水平数据(IPD)平台的可行性。
PLoS Negl Trop Dis. 2024 Apr 16;18(4):e0011635. doi: 10.1371/journal.pntd.0011635. eCollection 2024 Apr.
3
Arsenic exposure to mouse visceral leishmaniasis model through their drinking water linked to the disease exacerbation via modulation in host protective immunity: a preclinical study.
通过饮用水向感染内脏利什曼病的小鼠模型暴露砷与通过调节宿主保护性免疫导致疾病恶化有关:一项临床前研究。
Sci Rep. 2023 Dec 5;13(1):21461. doi: 10.1038/s41598-023-48642-z.
4
Co-infection of tuberculosis and parasitic diseases in humans: a systematic review.人类结核分枝杆菌与寄生虫病合并感染:系统评价。
Parasit Vectors. 2013 Mar 22;6:79. doi: 10.1186/1756-3305-6-79.